470 related articles for article (PubMed ID: 10604473)
21. Phosphorylation of protein phosphatase inhibitor-1 by Cdk5.
Bibb JA; Nishi A; O'Callaghan JP; Ule J; Lan M; Snyder GL; Horiuchi A; Saito T; Hisanaga S; Czernik AJ; Nairn AC; Greengard P
J Biol Chem; 2001 Apr; 276(17):14490-7. PubMed ID: 11278334
[TBL] [Abstract][Full Text] [Related]
22. A dopamine/D1 receptor/protein kinase A/dopamine- and cAMP-regulated phosphoprotein (Mr 32 kDa)/protein phosphatase-1 pathway regulates dephosphorylation of the NMDA receptor.
Snyder GL; Fienberg AA; Huganir RL; Greengard P
J Neurosci; 1998 Dec; 18(24):10297-303. PubMed ID: 9852567
[TBL] [Abstract][Full Text] [Related]
23. Activation of adenosine A2A and dopamine D1 receptors stimulates cyclic AMP-dependent phosphorylation of DARPP-32 in distinct populations of striatal projection neurons.
Svenningsson P; Lindskog M; Rognoni F; Fredholm BB; Greengard P; Fisone G
Neuroscience; 1998 May; 84(1):223-8. PubMed ID: 9522376
[TBL] [Abstract][Full Text] [Related]
24. AKT and CDK5/p35 mediate brain-derived neurotrophic factor induction of DARPP-32 in medium size spiny neurons in vitro.
Bogush A; Pedrini S; Pelta-Heller J; Chan T; Yang Q; Mao Z; Sluzas E; Gieringer T; Ehrlich ME
J Biol Chem; 2007 Mar; 282(10):7352-9. PubMed ID: 17209049
[TBL] [Abstract][Full Text] [Related]
25. Glutamate regulation of DARPP-32 phosphorylation in neostriatal neurons involves activation of multiple signaling cascades.
Nishi A; Watanabe Y; Higashi H; Tanaka M; Nairn AC; Greengard P
Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1199-204. PubMed ID: 15657149
[TBL] [Abstract][Full Text] [Related]
26. Negative regulation of cyclin-dependent kinase 5 targets by protein kinase C.
Sahin B; Hawasli AH; Greene RW; Molkentin JD; Bibb JA
Eur J Pharmacol; 2008 Mar; 581(3):270-5. PubMed ID: 18190909
[TBL] [Abstract][Full Text] [Related]
27. Mechanism of regulation of casein kinase I activity by group I metabotropic glutamate receptors.
Liu F; Virshup DM; Nairn AC; Greengard P
J Biol Chem; 2002 Nov; 277(47):45393-9. PubMed ID: 12223474
[TBL] [Abstract][Full Text] [Related]
28. Role of calcineurin and protein phosphatase-2A in the regulation of DARPP-32 dephosphorylation in neostriatal neurons.
Nishi A; Snyder GL; Nairn AC; Greengard P
J Neurochem; 1999 May; 72(5):2015-21. PubMed ID: 10217279
[TBL] [Abstract][Full Text] [Related]
29. Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine.
Lindskog M; Svenningsson P; Pozzi L; Kim Y; Fienberg AA; Bibb JA; Fredholm BB; Nairn AC; Greengard P; Fisone G
Nature; 2002 Aug; 418(6899):774-8. PubMed ID: 12181566
[TBL] [Abstract][Full Text] [Related]
30. DARPP-32 and modulation of cAMP signaling: involvement in motor control and levodopa-induced dyskinesia.
Håkansson K; Lindskog M; Pozzi L; Usiello A; Fisone G
Parkinsonism Relat Disord; 2004 Jul; 10(5):281-6. PubMed ID: 15196506
[TBL] [Abstract][Full Text] [Related]
31. Synthetic peptide analogs of DARPP-32 (Mr 32,000 dopamine- and cAMP-regulated phosphoprotein), an inhibitor of protein phosphatase-1. Phosphorylation, dephosphorylation, and inhibitory activity.
Hemmings HC; Nairn AC; Elliott JI; Greengard P
J Biol Chem; 1990 Nov; 265(33):20369-76. PubMed ID: 2173704
[TBL] [Abstract][Full Text] [Related]
32. Nitric oxide/cGMP pathway stimulates phosphorylation of DARPP-32, a dopamine- and cAMP-regulated phosphoprotein, in the substantia nigra.
Tsou K; Snyder GL; Greengard P
Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3462-5. PubMed ID: 8386374
[TBL] [Abstract][Full Text] [Related]
33. Activation of NMDA receptors induces dephosphorylation of DARPP-32 in rat striatal slices.
Halpain S; Girault JA; Greengard P
Nature; 1990 Jan; 343(6256):369-72. PubMed ID: 2153935
[TBL] [Abstract][Full Text] [Related]
34. Differential regulation of the Cdk5-dependent phosphorylation sites of inhibitor-1 and DARPP-32 by depolarization.
Nguyen C; Hosokawa T; Kuroiwa M; Ip NY; Nishi A; Hisanaga S; Bibb JA
J Neurochem; 2007 Nov; 103(4):1582-93. PubMed ID: 17868322
[TBL] [Abstract][Full Text] [Related]
35. Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors?
Leclerc S; Garnier M; Hoessel R; Marko D; Bibb JA; Snyder GL; Greengard P; Biernat J; Wu YZ; Mandelkow EM; Eisenbrand G; Meijer L
J Biol Chem; 2001 Jan; 276(1):251-60. PubMed ID: 11013232
[TBL] [Abstract][Full Text] [Related]
36. Effect of methylphenidate on dopamine/DARPP signalling in adult, but not young, mice.
Fukui R; Svenningsson P; Matsuishi T; Higashi H; Nairn AC; Greengard P; Nishi A
J Neurochem; 2003 Dec; 87(6):1391-401. PubMed ID: 14713295
[TBL] [Abstract][Full Text] [Related]
37. Repeated cocaine administration decreases calcineurin (PP2B) but enhances DARPP-32 modulation of sodium currents in rat nucleus accumbens neurons.
Hu XT; Ford K; White FJ
Neuropsychopharmacology; 2005 May; 30(5):916-26. PubMed ID: 15726118
[TBL] [Abstract][Full Text] [Related]
38. Neurotensin regulates DARPP-32 thr34 phosphorylation in neostriatal neurons by activation of dopamine D1-type receptors.
Matsuyama S; Higashi H; Maeda H; Greengard P; Nishi A
J Neurochem; 2002 Apr; 81(2):325-34. PubMed ID: 12064480
[TBL] [Abstract][Full Text] [Related]
39. Motor Skill Learning Is Associated with Phase-Dependent Modifications in the Striatal cAMP/PKA/DARPP-32 Signaling Pathway in Rodents.
Qian Y; Forssberg H; Diaz Heijtz R
PLoS One; 2015; 10(10):e0140974. PubMed ID: 26488498
[TBL] [Abstract][Full Text] [Related]
40. The mesolimbic dopaminergic response to novel palatable food consumption increases dopamine-D1 receptor-mediated signalling with complex modifications of the DARPP-32 phosphorylation pattern.
Rauggi R; Scheggi S; Cassanelli A; De Montis MG; Tagliamonte A; Gambarana C
J Neurochem; 2005 Feb; 92(4):867-77. PubMed ID: 15686489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
